The mRNA COVID-19 vaccine – a rare trigger of Autoimmune Hepatitis?
We read with interest the letters “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) Vaccine: Causality or casualty?” by Bril et al.1 and “Autoimmune hepatitis following sars-cov-2 VACCINE: MAY not be a casualty” by Rocco et al2 which highlight the hypothesis that COVID-19 mRNA-based vaccines might in crease the risk of developing autoimmune diseases. There are growing reports of autoimmune diseases developing after Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, including Guillain-Barré syndrome and Primary Biliary Cholangitis3.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Cathy McShane, Clifford Kiat, Jonathan Rigby, Órla Crosbie Tags: Letter to the Editor Source Type: research
More News: Autoimmune Disease | Coronavirus | COVID-19 | Gastroenterology | Guillain-Barr Syndrome | Hepatitis | Hepatitis Vaccine | Respiratory Medicine | SARS | Vaccines